Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 12/12/2018
SIETES contiene 92610 citas

 
 
 1 a 20 de 23 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Anónimo. Rifaximine et encéphalopatie hépatique. Prescrire 2017;37:175-6. [Ref.ID 101454]
2. Cita con resumen
Zhang F, Mamtani R, Scott FI, Goldberg DS, Haynes K, Lewis JD. Increasing use of prescription drugs in the United Kingdom. Pharmacoepidemiol Drug Saf 2016;25:628-36. [Ref.ID 100019]
3.Tiene citas relacionadas
Doran AE, Shah NL. Polyethylene glycol for hepatic encephalopathy. A new solution to purge an old problem?. JAMA Intern Med 2014;174:1734-5. [Ref.ID 98316]
4.Tiene citas relacionadas Cita con resumen
Rahimi RS, Singal AG, Cuthbert JA, Rockey DC. Lactulose vs polyethylene glycol 3350-electrolyte solution for treatment of overt hepatic encephalopathy. The HELP randomized clinical trial. JAMA Intern Med 2014;174:1727-33. [Ref.ID 98315]
5.
Ford AC, Talley NJ. Laxatives for chronic constipation in adults. BMJ 2012;345:44-7. [Ref.ID 94087]
6. Cita con resumen
Anónimo. The management of constipation. MeReC Bulletin 2011;21:1-8. [Ref.ID 89969]
7. Cita con resumen
Córdoba J, Mínguez B, Vergara M. Treatment of hepatic encephalopathy. Lancet 2005;365:1384-5. [Ref.ID 73445]
8. Cita con resumen
Blei AT. Treatment of hepatic encephalopathy. Lancet 2005;365:1383-4. [Ref.ID 73444]
9. Cita con resumen
Als-Nielsen B, Gluud LL, Gluud C. Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials. BMJ 2004;328:1046-50. [Ref.ID 69924]
10.
Lembo A, Camilleri M. Chronic constipation. N Engl J Med 2003;349:1360-8. [Ref.ID 67715]
11.
Battle M, Martin T, Fulton J. Lactulose may help prevent urinary tract infections. BMJ 2001;323:936. [Ref.ID 59237]
12.
Curioso WH, Monkemuller KE. Neomycin should not be used to treat hepatic encephalopathy. BMJ 2001;323:233. [Ref.ID 57642]
13.
Horwitz BJ, Fisher RS. The irritable bowel syndrome. N Engl J Med 2001;344:1846-50. [Ref.ID 56896]
14.
Krige JEJ, Beckingham IJ. Portal hypertension - 2. Ascites, encephalopathy, and other conditions. BMJ 2001;322:416-8. [Ref.ID 55296]
15.
Gerber T, Schomerus H. Hepatic encephalopathy in liver cirrhosis: pathogenesis, diagnosis and management. Drugs 2000;60:1353-70. [Ref.ID 54221]
16.
Chassany O, Michaux A, Bergmann J-F. Drug-induced diarrhoea. Drug Saf 2000;22:53-72. [Ref.ID 48624]
17. Cita con resumen
Anónimo. The management of constipation. MeReC Bulletin 1999;10:33-6. [Ref.ID 48253]
18. Cita con resumen
Calvert RT. Clinical pharmacy - a hospital perspective. Br J Clin Pharmacol 1999;47:231-8. [Ref.ID 44744]
19.
Anónimo. Huile de parafine + lactulose. Prescrire 1997;17:398-9. [Ref.ID 32535]
20.
Clausen MR, Mortensen PB. Lactulose, disaccharides and colonic flora: clinical consequences. Drugs 1997;53:930-42. [Ref.ID 32465]
Seleccionar todas
 
 1 a 20 de 23 siguiente >>